首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003.
【24h】

International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003.

机译:国际辅助生殖技术监测委员会(ICMART)世界报告:2003年辅助生殖技术。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To analyze information on assisted reproductive technologies (ART) performed globally. DESIGN: Data on access, efficacy, and safety of ART were collected for the year 2003 from 54 countries. SETTING: National and regional ART registries globally. PATIENT(S): Patients undergoing ART globally. INTERVENTION(S): Collection and analysis of international ART registry data. MAIN OUTCOME MEASURE(S): Number of cycles performed in reporting countries and regions globally for different ART procedures with resulting pregnancy, live birth and multiple birth rates. RESULT(S): A total of 433,427 initiated cycles reported in this registry resulted in 173,424 babies born. This corresponded to a delivery rate per aspiration of 22.4% for in vitro fertilization (IVF), 23.3% for intracytoplasmic sperm injection (ICSI), and a delivery rate per transfer of 17.1% for frozen embryo transfer. Although there is wide variation among countries and regions, the overall proportion of deliveries with twins and triplets from IVF and ICSI was 24.8% and 2.0%, respectively. There were wide variations in access, and compared with the previous report (year 2002), there was a 3.9% increase in the number of reported cycles and a minor increase in the delivery rate per aspiration. There was also a marginal decline in the mean number of embryos transferred and in the rate of multiple births. CONCLUSION(S): ART access, efficacy, and safety varies greatly globally. Collection and analysis of data over time will benefit ART patients, providers, and policy makers.
机译:目的:分析全球范围内有关辅助生殖技术(ART)的信息。设计:2003年收集了来自54个国家的抗逆转录病毒疗法的获取,疗效和安全性数据。单位:全球的国家和地区ART注册机构。患者:全球接受抗逆转录病毒治疗的患者。干预措施:国际ART注册管理机构数据的收集和分析。主要观察指标:报告国家和地区在全球范围内针对不同抗逆转录病毒治疗程序所进行的周期数,从而导致怀孕,活产和多胎出生。结果:该登记处报告的总共433,427个启动周期导致173,424例婴儿出生。这对应于体外受精(IVF)的每次抽吸递送率为22.4%,胞浆内精子注射(ICSI)的每次抽吸递送率为23.3%,以及冷冻胚胎移植的每次转移递送率为17.1%。尽管国家和地区之间差异很大,但IVF和ICSI的双胞胎和三胞胎分娩的总比例分别为24.8%和2.0%。获取途径的差异很大,与上一份报告(2002年)相比,报告的周期数增加了3.9%,每次抽吸的分娩率略有增加。转移的平均胚胎数和多胎出生率也略有下降。结论:全球范围内ART的获取,疗效和安全性差异很大。随着时间的推移收集和分析数据将使ART患者,提供者和决策者受益。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号